Tissue‐Adaptive BSA Hydrogel with Dual Release of PTX and bFGF Promotes Spinal Cord Injury Repair via Glial Scar Inhibition and Axon Regeneration
Small · 2024-12 · 20 (51)
DOI: 10.1002/smll.202401407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 10.10.2024. Verfasst von Sipin Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Hydrogels, Fibroblast Growth Factor 2, Axons. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Wenzhou Municipal Science & Technology Bureau of China.
Abstract (Originalsprache)
Spinal cord injury (SCI) is a severe clinical disease usually accompanied by activated glial scar, neuronal axon rupture, and disabled motor function. To mimic the microenvironment of the SCI injury site, a hydrogel system with a comparable mechanical property to the spinal cord is desirable. Therefore, a novel elastic bovine serum albumin (BSA) hydrogel is fabricated with excellent adhesive, injectable, and biocompatible properties. The hydrogel is used to deliver paclitaxel (PTX) together with basic fibroblast growth factor (bFGF) to inhibit glial scar formation as well as promote axon regeneration and motor function for SCI repair. Due to the specific interaction of BSA with both drugs, bFGF, and PTX can be controllably released from the hydrogel system to achieve an effective concentration at the wound site during the SCI regeneration process. Moreover, benefiting from the combination of PTX and bFGF, this bFGF/PTX@BSA system significantly aided axon repair by promoting the elongation of axons across the glial scar with reduced reactive astrocyte secretion. In addition, remarkable anti‐apoptosis of nerve cells is evident with the bFGF/PTX@BSA system. Subsequently, this multi‐functionalized drug system significantly improved the motor function of the rats after SCI. These results reveal that bFGF/PTX@BSA is an ideal functionalized material for nerve repair in SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), Wenzhou, Zhejiang, 325000, China.
ORCID-Profile: Huacheng He
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Wenzhou Municipal Science & Technology Bureau of China
Zitieren
APA
Zhu, S., Wu, Q., Ying, Y., Mao, Y., Lu, W., Xu, J., Cai, X., He, H., & Wu, J. (2024). Tissue‐Adaptive BSA Hydrogel with Dual Release of PTX and bFGF Promotes Spinal Cord Injury Repair via Glial Scar Inhibition and Axon Regeneration. Small, 20(51). https://doi.org/10.1002/smll.202401407
Vancouver
Zhu S, Wu Q, Ying Y, Mao Y, Lu W, Xu J, et al. Tissue‐Adaptive BSA Hydrogel with Dual Release of PTX and bFGF Promotes Spinal Cord Injury Repair via Glial Scar Inhibition and Axon Regeneration. Small. 2024;20(51). doi:10.1002/smll.202401407
BibTeX
@article{Zhu2024,
author = {Zhu, Sipin and Wu, Qiuji and Ying, Yibo and Mao, Yuqin and Lu, Wenjie and Xu, Jie and Cai, Xiong and He, Huacheng and Wu, Jiang},
title = {Tissue‐Adaptive BSA Hydrogel with Dual Release of PTX and bFGF Promotes Spinal Cord Injury Repair via Glial Scar Inhibition and Axon Regeneration},
journal = {Small},
year = {2024},
volume = {20},
number = {51},
doi = {10.1002/smll.202401407}
}
EUVIMED